LHC
EW icon

Little House Capital’s Edwards Lifesciences EW Stock Holding History

Little House Capital’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,622
Closed -$1.22M – 157
2021
Q1 		$1.22M Buy
+14,622
New +$1.24M 0.43% 62

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Little House Capital's EW Position: Q2 2021 in Review

Little House Capital sold out of Edwards Lifesciences (EW) in Q2 2021, closing a stake of 14,622 shares — an estimated $1.22M sold.

Little House Capital first reported a position in EW in Q1 2021 and held it in 1 quarter. The position peaked at $1.22M in Q1 2021. 1,188 funds tracked by Wall St. Rank hold EW as of Q2 2021.

  • Little House Capital reported no remaining Edwards Lifesciences position as of Q2 2021 after selling out during the quarter.
  • Little House Capital sold 14,622 Edwards Lifesciences shares in Q2 2021, an estimated $1.22M.
  • Little House Capital first reported a position in Edwards Lifesciences in Q1 2021 and held it in 1 quarter.
  • Little House Capital's Edwards Lifesciences position peaked at $1.22M in Q1 2021.
  • 1,188 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2021.

Based on Little House Capital's 13F filing for Q2 2021, filed 16 Aug 2021.